New COVID-19 testing services for colleges, universities, private companies and public agencies
TESTING FOR YOUR STUDENTS ON CAMPUS AND FOR EMPLOYEES IN THE WORK PLACE!
Fast and reliable results from the latest technology for COVID-19 RT-PCR, antigen and antibody testing
OccuMed of New England, an EquipNet Company, and ARCpoint Labs have formed an alliance to provide a fast, reliable, and advanced process for COVID-19 testing, a critical component for determining the health and safety of the entire school or business campus. Using Sofia 2 SARS Antigen FIA, a diagnostic testing tool designed for rapid detection of the virus, we can assist colleges, universities, and public agencies in their effort to control the spread of COVID-19.
Sofia 2 COVID-19 Antigen Test
Sofia 2, was recently approved by the FDA for emergency use authorization for a COVID-19 antigen test. Sofia 2 is an exceptional testing tool with many features and benefits including:
- Rapid results (results in 15 minutes)
- Objective, accurate results
- Dual work modes to conduct both the antigen and antibody test
- Easy to use
- Fluorescent technology with automated read
- Clean, easy to use and dispose of
Health and Safety Medical Technicians (HSMTS) at Your Location
Our specialized team of Health and Safety Medical Technicians (HSMTs) at OccuMed of New England can conduct antigen and antibody tests on-campus to provide results for any students and employees tested. Our HSMTs will come directly to campus to meet the needs of testing at your convenience.
Test results are available in as little as 15 minutes or next day turn around!
Sofia 2 Sars Antigen Fia Information Resource
Patient Fact Sheet
Antigen vs Antibody Testing
RT- PCR, DNA Swab Testing
PURCHASE YOUR VOUCHER FOR COVID-19 TESTING AT ONE OF OUR WALK-IN CLINICS
Antigen tests reveal if a person is currently infected with a pathogen such as the SARS-CoV-2 virus. Once the infection has gone, the antigen disappears. Antigen tests are typically used for early identification of an active infection in symptomatic patients.
Antibody tests reveal if a person has already been exposed to an infection and identify active (IgM) or past (IgG) infections by looking for antibodies against the specific virus. Antibody tests look for exposure to a pathogen resulting in the generation of an immune response, e.g. increase in IgG/IgM antibodies. This typically cannot diagnose the disease immediately after exposure, as antibodies may take 1-3 weeks to develop.
The RT-PCR, DNA test determines if the individual is infected with SARS-CoV-2 and considered to be able to transmit the disease (a positive test) or is negative for the virus. This test cannot tell whether a person is immune from past infection or has yet to be exposed and is still in danger. This test is required to travel into certain states in New England, like Maine. See state guidelines for up to date information.
